Alzheimer's Association Statement on New Clinical Trial Results Reported at AAIC 2022
August 03, 2022
August 03, 2022
CHICAGO, Illinois, Aug. 3 (TNStalk) -- The Alzheimer's Association issued the following agency statement on Aug. 2, 2022:
* * *
The Alzheimer's Association(R) is pleased to highlight results from a variety of clinical trials, which address multiple aspects of the disease, at the Alzheimer's Association International Conference(R) (AAIC(R)) 2022. We know that Alzheimer's and other dementia are complex diseases, and we envision a future of effective tr . . .
* * *
The Alzheimer's Association(R) is pleased to highlight results from a variety of clinical trials, which address multiple aspects of the disease, at the Alzheimer's Association International Conference(R) (AAIC(R)) 2022. We know that Alzheimer's and other dementia are complex diseases, and we envision a future of effective tr . . .